Aptamer–Drug Conjugation for Targeted Tumor Cell Therapy

Methods in Molecular Biology

Volumn 764, Issue , 2011, Pages 141-152

  Donovan, Michael J ^a   Meng, Ling ^a   Chen, Tao ^a   Zhang, Yunfei ^a   Sefah, Kwame ^a   Tan, Weihong ^a  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

cancer; DNA aptamer; SELEX; targeting ligands; therapeutic agents; therapy

Indexed keywords

ANTINEOPLASTIC AGENT; APTAMER; BIOTIN; DOXORUBICIN; LIGAND; STREPTAVIDIN;

ARTICLE; CHEMISTRY; COMBINATORIAL CHEMISTRY; HUMAN; LEUKEMIA; METABOLISM; METHODOLOGY; MOLECULARLY TARGETED THERAPY; PATHOLOGY; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; APTAMERS, NUCLEOTIDE; BIOTIN; CELL LINE, TUMOR; DOXORUBICIN; HUMANS; LEUKEMIA; LIGANDS; MOLECULAR TARGETED THERAPY; SELEX APTAMER TECHNIQUE; STREPTAVIDIN;

EID: 79960935792     PISSN: 10643745     EISSN: 19406029     Source Type: Book Series    
DOI: 10.1007/978-1-61779-188-8_9     Document Type: Chapter

References (10)

1. Tuerk, C., and Gold. L. (1990) Systematic evolution of ligands by exponential enrichment –RNA ligands to bacteriophage-T4 DNA-polymerase. Science 249, 505–510.
2. Ellington, A. D., and Szostak, J. W. (1990) In vitro selection of RNA molecules that bind specific ligands. Nature 346, 818–822.
3. Xiaohong, F., and Weihong T. (2010) Aptamers generated from Cell-SELEX for molecular medicine: a chemical biology approach. Accounts Chem Res 43, 48–57.
4. Shangguan, D., Li, Y., Tang, Z. W., Cao, Z. H. C., Chen, H. W., Mallikaratchy, P., Sefah, K., Yang, C. Y. J., and Tan, W. H. (2006) Aptamers evolved from live cells as effective molecular probes for cancer study. Proc Nat Acad Sci USA 103, 11838–11843.
5. Shamah, S. M., Healy, J. M., and Cload, S. T. (2008) Complex target SELEX. Accounts Chem Res 41, 130–138.
6. Shangguan, D., Cao, Z. H., Meng, L., Mallikaratchy, P., Sefah, K., Wang, H., Li, Y., and Tan, W. H. (2008) Cell-specific aptamer probes for membrane protein elucidation in cancer cells. J Proteome Res 7, 2133–2139.
7. Mallikaratchy, P., Tang, Z. W., Kwame, S., Meng, L., Shangguan, D. H., and Tan, W. H. (2007) Aptamer directly evolved from live cells recognizes membrane bound immunoglobin heavy mu chain in Burkitt’s lymphoma cells. Mol Cell Proteomics 6, 2230–2238.
8. Lee, J. H., Canny, M. D., De Erkenez, A., Krilleke, D., Ng, Y. S., Shima, D. T., Pardi, A., and Jucker, F. (2005) A therapeutic aptamer inhibits angiogenesis by specifically targeting the heparin binding domain of VEGF165. Proc Natl Acad Sci USA 102, 8902–18907.
9. Fraunfelder, F. W. (2005) Pegaptanib for wet macular degeneration. Drugs Today 41, 703–709.
10. Huang, Y-. F., Shangguan, D., Liu, H., Phillips, J. A., Zhang, X., Chen, Y., and Tan, W. (2009) Molecular assembly of an aptamer-drug conjugate for targeted drug delivery to tumor cells. ChemBiochem 10, 862–868.